SAN FRANCISCO BAY AREA, California – Real Time Genomics, Inc. (RTG), the genome analytics company, today announced a long-term strategic collaboration with the J. Craig Venter Institute (JCVI), a not-for-profit genomic research institute, aimed at understanding and analyzing the genetic changes that induced pluripotent stem cells may acquire during the process of differentiation. RTG and […]
Menlo Park, CA – Personalis today announced the appointment of Michael Fitzpatrick as Vice President Worldwide Sales. Mr. Fitzpatrick brings substantial experience in sales and sales operations in the life science industry, specifically related to DNA sequencing. In this newly created position, Mr. Fitzpatrick will be instrumental in helping drive the next phase of the […]
LEXINGTON, Mass – RainDance Technologies, Inc., the Digital Biology™ Company, today announced the closing of a $20 million Series E financing round. The company also announced that Myriad Genetics, Inc. (Nasdaq: MYGN) has joined as a new strategic equity investor. The two companies recently announced a multi-year commercial supply agreement whereby Myriad has adopted RainDance’s […]
Centrillion Biosciences, a leading genomic and bioinformatics solution provider, has announced a new grant program focused on innovation in the application of next-gen sequencing technology. The Sequencing Innovation Grant award is open to academic, clinical and industrial researchers. The Grant will be awarded to research proposals demonstrating innovative applications of next generation sequencing technology. Grants […]
Reorganisation of Roche Applied Science – part of Roche’s Diagnostics Division – designed to enhance responsiveness to scientific and market needs and technology flow from research use to the clinical setting. Changes expected to affect approximately 110 positions in Penzberg (Germany) and 60 positions in Branford (Connecticut, USA). Roche remains committed to life-science business. Roche […]
LEXINGTON, Mass. –– RainDance Technologies, Inc., the Digital Biology™ company, today announced a new Service Partner Program for its growing base of research customers who are developing next-generation sequencing-based genetic testing panels to identify and characterize inherited diseases, cancers and other human health conditions in research projects. Through this new program, customers have expanded access […]
Appistry, Inc., which provides a big-data computing environment that supports life-science and medical analytics and workflows, announced today a collaborative partnership and value-added reseller agreement with LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX). The intent of the partnership is to integrate LifeMap’s GeneCards® and MalaCards databases of human genes and diseases into […]
London, United Kingdom – DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today confirms that it will be continuing the development of a semiconductor sequencing platform after Roche passes its project to DNA Electronics. DNA Electronics now plans to take the project forward, differentiated with a new focus that […]
GLASGOW, Scotland, — Life Technologies Corporation (NASDAQ: LIFE) today announces that it is a lead commercial partner along with Aridhia, a bio-medical informatics company, in the Stratified Medicine Scotland Innovation Centre (SMS-IC). The Ion Proton ™ sequencing platform will be the primary tool to drive discovery and genetic analysis as SMS-IC aspires to be a […]
Biomedical informatics company Aridhia today announced that it is a lead commercial partner alongside Life Technologies Corporation, a global biotechnology tools company, in the Stratified Medicine Scotland Innovation Centre (SMS-IC). The SMS-IC is a unique collaboration bringing together expertise from within Scottish industry, academia and the NHS to drive forward a new age of stratified […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
